Stockreport

Bristol-Myers Squibb's azacitidine granted additional indication for juvenile leukemia [Seeking Alpha]

Bristol-Myers Squibb Company  (BMY) 
Last bristol-myers squibb company earnings: 2/6 07:05 am Check Earnings Report
US:NYSE Investor Relations: bms.com/investors.html
PDF Bristol-Myers Squibb's azacitidine granted additional indication for juvenile leukemiaMay 20, 2022 4:54 PM ETBristol-Myers Squibb Company ()By:Jonathan BlockSA News Edit [Read more]